More Company News

Avacta

Restoration of trading on AIM
06 Oct 2026Read More

Avacta

Results of placing and subscription
06 Oct 2026Read More

Avacta

Capital access window
30 Sep 2026Read More

Avacta

Interim H126 results
30 Sep 2026Read More

Avacta

Further demonstration of AVA6103 potential at AACR Conference on Pancreatic Cancer
25 Sep 2026Read More

Avacta

Clinical proof of mechanism for preCISION platform
16 Sep 2026Read More

Avacta

Accelerated amortized payment of bond instalment
09 Jul 2026Read More

Avacta

New deputy chair
08 Jul 2026Read More

Avacta

Platform-validating data with faridoxorubicin
25 Jun 2026Read More

Avacta

FDA agreement on pivotal trial design for AVA6000
25 Jun 2026Read More

1 2 3 4 … 14
Return to Avacta
© 2019-2026 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).